Matches 1 - 50 out of 57 1 2 >


Match Document Document Title
US20110150929 SARS vaccine compositions and methods of making and using them  
Described is a composition and method for reducing the occurrence and severity of infectious diseases, especially infectious diseases such as SARS, in which lipid-containing infectious viral...
US20110117129 Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS)  
The present invention is related to methods and attenuated viral compositions for use in preventing and treating a high fever disease forms associated with porcine reproductive and respiratory...
US20110135685 Edible Vaccines Expressed in Soybeans  
The present invention relates to vaccines that are made in transgenic soybeans for use in humans, animals of agricultural importance, pets, and wildlife. These vaccines are used as vaccines...
US20120003277 NANOEMULSION VACCINES  
The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides nanoemulsion compositions harboring one or more...
US20140271710 LIQUID STABLE BOVINE VIRUS VACCINES  
The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, in sucrose, arginine, and methionine. The present invention also discloses the manufacture of...
US20150056246 SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES  
The present invention relates to a probiotic cell transformed with a construct suitable to overexpress and display on the surface of the probiotic cell a fusion protein comprising at least a...
US20110150940 DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION  
This invention provides a dry powder composition for poultry vaccination via inhalation comprising an effective amount of a poultry vaccine agent, and a supporting amount of carriers for said...
US20140271709 BOVINE VIRUS VACCINES THAT ARE LIQUID STABLE  
The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, and a sugar alcohol. The present invention also discloses the manufacture of such vaccines and...
US20150157706 CANINE RESPIRATORY CORONAVIRUS FOR TREATMENT AND PROTECTION AGAINST BACTERIAL INFECTIONS  
Provided herein are compositions, combinations, and methods comprising Canine Respiratory Coronavirus (CRCoV), which are effective in treating or preventing respiratory infections associated...
US20120244182 USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION  
The invention provides immunostimulatory compositions and methods of administration thereof. Also provided are methods of administering a tryptanthrin compound in an effective amount to enhance...
US20110177116 Methods of Immunizing Pregnant Heifers at Three Months of Gestation  
The present invention discloses methods for protecting newborn calves against neonatal diarrhea by vaccinating pregnant cows and/or pregnant heifers, while minimizing the number of separate...
US20130224244 VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD)  
A vaccine composition for vaccinating dogs comprising any one or more of (a) an agent capable of raising an immune response against Streptococcus equi sub species zooepidemicus in a dog, (b) an...
US20110212123 Immunogenic Substances Comprising a Polyinosinic Acid - Polycytidilic Acid Based Adjuvant  
The present invention provides a polynucleotide adjuvant (PICKCa) composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The polynucleotide...
US20110236419 RECOMBINANT CDV COMPOSITIONS AND USES THEREOF  
The present invention provides vectors that contain and express in vivo or in vitro CDV polypeptides or antigens that elicit an immune response in animal against CDV, compositions comprising said...
US20100040576 Modified Oligonucleotides For The Treatment Of Hepatitis C Infection  
The invention relates to compositions and methods related to the treatment of viral infection. In some embodiments, the invention relates to the treatment of hepatitis C viral infection. In...
US20100158947 PERMISSIVE CELLS AND USES THEREOF  
The invention relates generally to the field of virology. More particularly, the present invention relates to methods for determining the permissiveness of a cell for a virus that is a member of...
US20070298093 Synergistic Liposomal Adjuvants  
The present invention relates to liposome, mixtures or liposomes and liposomal compositions comprising at least two different adjuvants and a therapeutic agent, their production and use for the...
US20090041852 DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION  
This invention provides a dry powder composition for poultry vaccination via inhalation comprising an effective amount of a poultry vaccine agent, and a supporting amount of carriers for said...
US20100028379 METHODS OF VACCINE ADMINISTRATION  
This invention relates to a method of treating a dog for canine diseases comprising administering to the dog therapeutically effective amounts of a vaccine, wherein the vaccine comprises viral...
US20080118530 Modulation of Replicative Fitness By Deoptimization of Synonymous Codons  
Methods of producing a pathogen with reduced replicative fitness are disclosed, as are attenuated pathogens produced using the methods. In particular examples, the method includes deoptimizing one...
US20100104599 Compositions and Methods For Enhancing Immune System of Felines  
Compositions and methods useful to enhance the development of the immune system of a growing animal are disclosed.
US20060093616 Process for vaccinating eucaryotic hosts and for protecting against SARS-CoV infection  
The present invention relates to a process for vaccinating humans and for protecting against SARS-CoV infection.
US20100172937 ENVELOPED VIRUS NEUTRALIZING COMPOUNDS  
Methods for reducing infectivity by providing an enveloped virus neutralizing compound (EVNC) are provided. Methods of preparing a vaccine, vaccine formulations, and methods of immunizing a...
US20140141041 RAPID AND PROLONGED IMMUNOLOGIC-THERAPEUTIC  
The present invention shows that intranasal administration of E1/E3-defective adenovirus particles may confer rapid and broad protection against viral and bacterial pathogens in a variety of...
US20090017069 SARS Vaccine Compositions and Methods of Making and Using Them  
Described is a composition and method for reducing the occurrence and severity of infectious diseases, especially infectious diseases such as SARS, in which lipid-containing infectious viral...
US20120269848 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFECTION  
This invention relates to cholesterol-sequestering agents and methods of using cholesterol-sequestering agents to treat or prevent infection. The compositions of the invention can be used in vitro...
US20080063664 High-yield transgenic mammalian expression system for generating virus-like particles  
The present invention provides a method utilizing mammalian expression system for generating virus-like particles (VLPs) of mammalian-hosted viruses, particularly SARS-CoV. The method of the...
US20080220018 VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE(CIRD)  
A vaccine composition for vaccinating dogs comprising any one or more of (a) an agent capable of raising an immune response against Streptococcus equi sub species zooepidemicus in a dog, (b) an...
US20100233204 Immunogenic Compositions and Methods for Treating and Preventing Animal Infections  
The present disclosure relates to multivalent immunogen compositions for treating or preventing diseases or disorders in canines caused by or associated with one or more of canine distemper virus,...
US20100028383 Chemically defined stabiliser  
The present invention relates to a stabiliser composition comprising an amino acid, and a sugar wherein all compounds are chemically defined; to a vaccine composition comprising such a stabiliser...
US20130045229 Anti-Viral Compounds  
Disclosed herein are compounds and related compositions for the treatment of viral infection, including RNA viral infection, and compounds that can modulate the RIG-I pathway in vertebrate cells,...
US20080044426 Novel Atypical Pneumonia-Causing Virus  
The invention relates to the field of virology. The invention provides a new isolated essentially mammalian positive-sense single stranded RNA virus (EMCR-CoV) within the group of coronaviuses and...
US20070219149 Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity  
The present invention provides an adjuvant that possesses a greater adjuvant potential than that of a conventional adjuvant, and that is capable of producing a protective reaction across different...
US20090017052 Methods of determining lethality of pathogens and malignancies involving replikin peak genes  
The present invention provides methods of identifying lethal, virulent and rapidly replicating viruses, organisms, and malignancies comprising comparing Replikin concentrations among different...
US20100266628 MACROCYCLIC LACTONE COMBINATION COMPOSITIONS, VACCINES AND METHODS FOR PRODUCING SAME  
An injectable composition, capable of preventing or controlling parasitic, viral, or bacterial infections or diseases, for example scours, in pregnant cows and viral infections or diseases in...
US20060292178 Proteins encoded by the severe acute respiratory syndrome (SARS) coronavirus and a role in apoptosis  
Compositions related to expressed severe acute respiratory syndrome (SARS) coronavirus group-specific polypeptides are provided. Further provided are methods and compositions related to the use of...
US20050002953 SARS-coronavirus virus-like particles and methods of use  
The present disclosure describes a system for making SARS-CoV-virus-like particles (SARS-CoV-VLPs) comprising one or more recombinant vectors which express the SARS-CoV E-protein, the SARS-CoV...
US20100247537 ADJUVANT COMBINATIONS OF NKT ACTIVATOR, CD40 AGONIST, AND OPTIONAL ANTIGEN, THE USE THROUGH INDUCING SYNERGISTIC CELLULAR IMMUNITY  
Adjuvant combinations comprising at least one NKT activator, such as alpha-galactosylceramide (α-Gal-Cer) or iGb3, a CD40 agonist and optionally an antigen are disclosed. The use of these immune...
US20060286124 Vaccine compositions and methods of treating coronavirus infection  
The present disclosure relates to compositions and methods for treating or preventing coronavirus infections. For example, compositions are provided that comprise a coronavirus S protein or N...
US20050025788 Systemic delivery of non-viral vector expressing SARS viral genomic vaccine  
The present invention relates to a non-viral vector for SARS Viral Genomic Vaccine. The present invention also relates to a non-targeted lipoplex or PEGylated lipoplex formulation for accumulating...
US20070190065 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with SARS corona virus spike protein  
Nucleic acid molecules, polypeptides, immunogenic compositions, vaccines, and methods of making and using the nucleotides and encoded polypeptides associated with the Spike protein of SARS Corona...
US20090324643 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFECTION  
This invention relates to cholesterol-sequestering agents and methods of using cholesterol-sequestering agents to treat or prevent infection. The compositions of the invention can be used in vitro...
US20070003577 Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections  
Immunogenic compositions and vaccines associated with the Spike protein of SARS Corona Virus (SARS CoV) are disclosed.
US20080026071 Microparticles for delivery of heterologous nucleic acids  
Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(α-hydroxy acid), a polyhydroxy...
US20100266634 ADJUVANCY AND IMMUNE POTENTIATING PROPERTIES OF NATURAL PRODUCTS OF ONCHOCERCA VOLVULUS  
The present invention relates to a method for potentiating a specific immune response to an antigen in a mammal in need thereof. The method comprises administering to the mammal an effective...
US20100047277 VIROSOMES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS  
Briefly described, virosomes, methods of preparing virosomes, immunogenic compositions that include virosomes, and methods of eliciting an immune response using immunogenic compositions that...
US20060171962 SARS vaccine  
The present invention is directed to vaccines comprising a virus particle comprising a nucleic acid and one or several coat proteins, wherein (a) the nucleic acid encodes SARS-CoV replicase,...
US20070258999 Sars Virus Nucleotide and Amino Acid Sequences and Uses Thereof  
The invention provides, in part, the genomic sequence of a putative coronavirus, the SARS virus, and provides novel nucleic acid and amino acid sequences that may be used, for example, for the...
US20070128224 Novel strain of sars-associated coronavirus and applications thereof  
The invention relates to a novel strain of severe acute respiratory syndrome (SARS)-associated coronavirus, resulting from a sample collected in Hanoi (Vietnam), reference number 031589, nucleic...
US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof  
The invention relates to a nucleic acid sequence comprising the RNA packaging signal of a group 1 coronavirus, such as transmissible gastroenteritis virus of swine (TGEV), which is located between...

Matches 1 - 50 out of 57 1 2 >